[HTML][HTML] May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients' questions? An evidence-controlled analysis
AG Gravina, R Pellegrino, M Cipullo… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Artificial intelligence is increasingly entering everyday healthcare. Large language model
(LLM) systems such as Chat Generative Pre-trained Transformer (ChatGPT) have become …
(LLM) systems such as Chat Generative Pre-trained Transformer (ChatGPT) have become …
[HTML][HTML] Combination treatment of inflammatory bowel disease: Present status and future perspectives
JK Triantafillidis, CG Zografos… - World Journal of …, 2024 - ncbi.nlm.nih.gov
The treatment of patients with inflammatory bowel disease (IBD), especially those with
severe or refractory disease, represents an important challenge for the clinical …
severe or refractory disease, represents an important challenge for the clinical …
[HTML][HTML] Efficacy of switching to adalimumab for maintenance of remission following induction therapy with tacrolimus in patients with ulcerative colitis
K Numa, K Kakimoto, Y Tanaka, N Mizuta… - Journal of Clinical …, 2023 - mdpi.com
Background: Tacrolimus (TAC) effectively induces remission in refractory ulcerative colitis
(UC). However, TAC therapy usually lasts for 3 months. Although azathioprine (AZA) is often …
(UC). However, TAC therapy usually lasts for 3 months. Although azathioprine (AZA) is often …
[PDF][PDF] Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
沼圭次朗， ヌマケイジロウ - ompu.repo.nii.ac.jp
Background: Tacrolimus (TAC) effectively induces remission in refractory ulcerative colitis
(UC). However, TAC therapy usually lasts for 3 months. Although azathioprine (AZA) is often …
(UC). However, TAC therapy usually lasts for 3 months. Although azathioprine (AZA) is often …